Fundación Intecnus

Fundación Intecnus
RP82 8400, San Carlos de Bariloche, Río Negro
Select an option
Open studies
Bladder Cancer
A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder - SunRISe-2 - Janssen Research & Development, LLCSee more
Lung cancer
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023] - MK-2870-023 - Merck Sharp & Dohme LLCSee more
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy